NAPHTHO(3,2-F)QUINOXALINE-7,12-DIONE
UNII JW9DZV2DT3

Substance Identification & Data

This profile provides standardized clinical and technical data for Naphtho(3,2-f)quinoxaline-7,12-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JW9DZV2DT3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 54490-26-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
JW9DZV2DT3
CAS Registry Number
54490-26-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NAPHTHO(3,2-F)QUINOXALINE-7,12-DIONE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H8N2O2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DGLSEJAACVWJNU-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=C1c2ccccc2C(=O)c3c1ccc4nccnc43

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naphtho(3,2-f)quinoxaline-7,12-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

7,12-DIHYDRO-7,12-DIOXOANTHRA(1,2-B)PYRAZINE
NAPHTHO(3,2-F)QUINOXALINE-7,12-DIONE